Acute cytomegalovirus infection and IgM anti-GM2 antibody

Journal of the Neurological Sciences

Volumn 154, Issue 1, 1998, Pages 14-17

  Yuki, Nobuhiro ^a   Tagawa, Yumi ^a,b  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b KAGAWA UNIVERSITY   (Japan)

Author keywords

Anti ganglioside antibody; Cytomegalovirus; GM2; Guillain Barre syndrome

Indexed keywords

BIOCHEMICAL MARKER; GANGLIOSIDE ANTIBODY; GANGLIOSIDE GD 1A; GANGLIOSIDE GD 1B; GANGLIOSIDE GD2; GANGLIOSIDE GD3; GANGLIOSIDE GM2; GANGLIOSIDE GM3; GANGLIOSIDE GQ 1B; GANGLIOSIDE GT 1B; IMMUNOGLOBULIN M;

ADULT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CRANIAL NEUROPATHY; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MALE; PRIORITY JOURNAL; SENSORY DYSFUNCTION; SEROLOGY;

ACUTE DISEASE; ADOLESCENT; ADULT; ANTIBODIES, VIRAL; CHROMATOGRAPHY, THIN LAYER; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; G(M2) GANGLIOSIDE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; POLYRADICULONEUROPATHY;

EID: 0032554122     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(97)00174-3     Document Type: Article

References (9)

1. Irie S., Saito T., Nakamura K., Kanazawa N., Ogino M., Nukazawa T., Ito H., Tamai Y., Kowa H. Association of anti-GM2 antibodies in Guillain-Barré syndrome with acute cytomegalovirus infection. J. Neuroimmunol. 68:1996;19-26.
2. Koblar S.A., Gregson N.A., Hughes R.A.C., Doherty P., Walsh F.S. Campylobacter neuropathy. Neurology. 41:1991;1327-1328.
3. Rees J.H., Gregson N.A., Hughes R.A.C. Anti-ganglioside GM1 antibodies in Guillain-Barré syndrome and their relationship to Campylobacter jejuni infection. Ann. Neurol. 38:1995;809-816.
4. Visser L.H., van der Meché F.G.A., Meulstee J., Rothbarth P.Ph., Jacobs B.C., Schmitz P.I.M., van Doon P.A. Dutch Guillain-Barré Study Group, Cytomegalovirus infection and Guillain-Barré syndrome: the clinical, electrophysiologic, and prognostic features. Neurology. 47:1996;668-673.
5. Visser L.H., van der Meché F.G.A., van Doon P.A., Meulstee J., Jacobs B.C., Oomes P.G., Kleyweg R.P. Dutch Guillain-Barré Study Group, Guillain-Barré syndrome without sensory loss (acute motor neuropathy): a subgroup with specific clinical, electrodiagnostic and laboratory features. Brain. 118:1995;841-847.
6. Winer J.B., Hughes R.A.C., Osmond C. A prospective study of acute idiopathic neuropathy. I. Clinical features and their prognostic value. J. Neurol. Neurosurg. Psychiatry. 51:1988;605-612.
7. Yuki N., Yoshino H., Sato S., Miyatake T. Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis [see comments]. Neurology 40, 1900-1902. Comment in: Neurology 41, 1327-1328. Comment in: Neurology. 41:1990;1530-1531.
8. Yuki N. Acute paresis of extraocular muscles associated with IgG anti-GQ1b antibody. Ann. Neurol. 36:1996;668-672.
9. Yuki N., Taki T., Handa S. Antibody to GalNAc-GD1a and GalNAc-GM1b in Guillain-Barré syndrome subsequent to Campylobacter jejuni enteritis. J. Neurimmunol. 71:1996;155-161.